Nucleotide Premix

Nucleotide Premix Market Outlook

The global nucleotide premix market is projected to reach approximately USD 1.5 billion by 2035, growing at a compound annual growth rate (CAGR) of around 8% during the forecast period from 2025 to 2035. The growth of this market can be attributed to the increasing demand for nucleotide supplements in the food and beverage industry, alongside the rising awareness regarding the health benefits of nucleotides in animal feed and human nutrition. Additionally, the growing pharmaceutical sector, particularly in the development of new therapies and medications, is further propelling the need for nucleotide premixes. The market is also witnessing innovations in product formulations and the development of new applications across various industries, thus enhancing its growth potential. Moreover, the increasing consumption of functional foods and dietary supplements is expected to provide a significant boost to market expansion over the next decade.

Growth Factor of the Market

The growth of the nucleotide premix market can be predominantly attributed to an increasing understanding of the nutritional benefits that nucleotides offer. With a growing population that is leaning towards health-conscious lifestyles, there is a noticeable surge in demand for nutritional supplements infused with nucleotides, which are known to play significant roles in metabolic processes and immune function. Additionally, the rising trend of pet ownership has led to a higher demand for quality animal feed, which often incorporates nucleotide premixes to enhance the health and growth of pets. This trend is particularly accentuated by the focus on animal welfare and the increased awareness of pet nutrition among consumers. Furthermore, advancements in food technology and the incorporation of nucleotides into functional foods and beverages are creating new avenues for market growth. The pharmaceutical industry is also witnessing a rise in the application of nucleotide premixes in drug formulations and therapeutic applications, which further strengthens the market landscape.

Key Highlights of the Market

• Significant growth projected in the nucleotide premix market with a CAGR of 8% from 2025 to 2035.
• Increasing applications in the pharmaceuticals, animal feed, and functional foods sectors.
• Rising consumer awareness regarding health benefits associated with nucleotides.
• Innovations in product formulations enhancing market offerings.
• Growing demand for quality animal nutrition driving product development.

By Product Type

Guanosine 5'-Monophosphate:

Guanosine 5'-Monophosphate (GMP) is one of the leading product types in the nucleotide premix market. It serves as a critical component in various biological processes and is known for its role in enhancing flavor in food products as well as promoting growth in animal feed. The demand for GMP is particularly high in the food and beverage industry, where it is utilized as a flavor enhancer and as a nutritional additive. Moreover, GMP has been recognized for its potential health benefits, such as improving immune function and athletic performance, thus contributing to its strong market presence. The increasing incorporation of GMP into functional food products is also expected to drive its demand, particularly among health-conscious consumers seeking to enhance their dietary intake.

Cytidine 5'-Monophosphate:

Cytidine 5'-Monophosphate (CMP) is gaining traction due to its important role in various biochemical pathways and its application in nutritional supplements. CMP is known for its contributions to cellular metabolism and is often included in formulations aimed at improving cognitive function and neurological health. The growing trend of incorporating nucleotides into dietary supplements has boosted the demand for CMP, particularly among the aging population seeking cognitive health solutions. Moreover, its application in animal nutrition to enhance growth and health in livestock is further propelling its market growth. The development of innovative CMP-rich products in the health and wellness sector is also contributing to increased market interest.

Adenosine 5'-Monophosphate:

Adenosine 5'-Monophosphate (AMP) is recognized for its critical role in energy metabolism and cellular function, making it a valuable component in nucleotide premixes. The market for AMP is primarily driven by its application in dietary supplements aimed at enhancing physical performance and recovery. Athletes and fitness enthusiasts are increasingly seeking products that contain AMP for its potential benefits in reducing fatigue and improving endurance. Additionally, the pharmaceutical sector has started to explore the therapeutic potential of AMP in various health conditions, which opens up new avenues for market growth. The increasing awareness of the benefits of nucleotides in sports nutrition is expected to sustain the demand for AMP in the coming years.

Uridine 5'-Monophosphate:

Uridine 5'-Monophosphate (UMP) is a nucleotide that plays a vital role in nucleic acid metabolism and is recognized for its potential neuroprotective effects. The growing interest in cognitive health and the prevention of neurodegenerative diseases has significantly increased the demand for UMP in dietary supplements. Moreover, UMP is also gaining popularity in the food industry as a flavor enhancer and as a nutritional additive due to its health-promoting properties. The incorporation of UMP into functional foods aimed at improving brain health and cognitive function is expected to drive its market growth. Additionally, the expanding research on UMP’s role in cellular signaling and overall health is likely to spur further interest in its application across various sectors.

Inosine 5'-Monophosphate:

Inosine 5'-Monophosphate (IMP) is well-known for its ability to enhance umami flavor in food products and is thus commonly used as a flavor enhancer in the food industry. The demand for IMP in the food and beverages sector continues to rise due to the increasing consumer preference for natural and clean-label products. Additionally, IMP is utilized in animal nutrition where it is believed to enhance growth performance and overall health in livestock. The burgeoning popularity of umami flavor has led to innovative product development that incorporates IMP, thus expanding its market reach. Furthermore, the research into the health benefits of IMP, including its potential role in energy metabolism and muscle recovery, is likely to further boost its demand in nutritional supplements.

By Application

Animal Feed:

The application of nucleotide premixes in animal feed is one of the most significant segments within the market, driven by the growing demand for high-quality animal nutrition. Increasing awareness regarding the nutritional benefits of nucleotides has led to their incorporation into livestock feed to improve growth rates, immunity, and overall health. The rising trend of premium pet food, which often includes nucleotide additives, is also contributing to market growth. Additionally, the shift towards sustainable and health-oriented animal farming practices has incentivized producers to utilize nucleotide supplements to promote animal welfare and product quality. The overall growth in the livestock sector and the increasing focus on animal health are expected to further propel the demand for nucleotide premixes in animal feed applications.

Food & Beverages:

The food and beverages sector is witnessing a surge in the application of nucleotide premixes as consumer preferences shift towards functional foods enriched with health benefits. Nucleotides are increasingly integrated into products aimed at enhancing nutritional profiles and improving flavors. The rise in demand for clean label and natural ingredients is driving food manufacturers to explore nucleotide premixes as a means to offer quality products. Furthermore, the growing popularity of fortified foods and beverages is contributing to the expansion of this application segment. The increasing awareness among consumers regarding the role of nucleotides in health and wellness is expected to sustain growth in this area over the forecast period.

Pharmaceuticals:

Nucleotide premixes are gaining traction in the pharmaceutical industry, particularly in the development of formulations aimed at various therapeutic applications. The significant role of nucleotides in cellular metabolism and their potential benefits in enhancing drug efficacy are driving their adoption in pharmaceutical research and development. Additionally, the growing focus on personalized medicine and the increasing prevalence of chronic diseases are leading to the exploration of nucleotide-based therapies. As the pharmaceutical sector continues to innovate, the demand for nucleotide premixes is expected to grow as they play a crucial role in the formulation of advanced therapies. The ongoing research into the therapeutic applications of nucleotides is likely to further expand their usage in this segment.

Cosmetics:

The incorporation of nucleotide premixes in cosmetics is a growing trend, driven by the increasing consumer demand for products that promote skin health and overall well-being. Nucleotides are known for their potential anti-aging properties, making them an attractive ingredient for cosmetics aimed at improving skin elasticity and hydration. The rising awareness of the benefits of natural and functional ingredients in personal care products is propelling this application segment. Furthermore, the growing popularity of skincare products that focus on cellular health and rejuvenation is expected to drive the demand for nucleotide-infused cosmetics. The integration of nucleotides in formulations targeting specific skin concerns is likely to enhance market growth in this area.

By Distribution Channel

Direct Sales:

Direct sales play a significant role in the distribution of nucleotide premixes, particularly as manufacturers and suppliers seek to establish direct relationships with their customers. This channel allows for better control over the supply chain and enables companies to respond quickly to market demands. Direct sales are commonly employed by companies aiming to target specific segments, such as pharmaceutical firms or large-scale food manufacturers. The ability to provide customized solutions and establish direct communication with clients enhances the overall customer experience, fostering long-term relationships. The increasing emphasis on personalized nutrition and tailored products is further supporting the growth of direct sales in the nucleotide premix market.

Indirect Sales:

Indirect sales channels, including wholesalers, distributors, and online platforms, are also integral to the nucleotide premix market, providing broader access to various customer segments. This distribution channel enables manufacturers to reach different markets efficiently, while also accommodating the growing trend of online shopping for health and nutritional products. The rising demand for convenience and accessibility among consumers is boosting the significance of indirect sales. Additionally, partnerships with distributors allow companies to leverage established networks and gain insights into regional market trends. As the market expands, the role of indirect sales channels is anticipated to grow alongside the diversification of product offerings.

By Ingredient Type

Yeast Extracts:

Yeast extracts are a prominent ingredient type in the nucleotide premix market, widely recognized for their rich nutritional profile and flavor-enhancing properties. These extracts are derived from yeast cells and are often utilized in various food products to enhance taste while providing essential nutrients, including nucleotides. The growing popularity of plant-based and fermented products is driving the demand for yeast extracts in both food and animal feed applications. Furthermore, the health benefits associated with yeast extracts, such as their potential to support gut health and overall immunity, are contributing to their increasing adoption across various sectors.

Fish Extracts:

Fish extracts are gaining traction within the nucleotide premix market due to their high content of essential amino acids and nucleotides. These extracts are predominantly used in animal feeds, particularly in aquaculture, where they contribute to the health and growth of fish stocks. The rising demand for sustainable aquaculture practices and high-quality fish products is propelling the market for fish extracts. Additionally, fish extracts are being explored for their potential health benefits in nutritional supplements aimed at enhancing cognitive function and heart health, thus broadening their application across food and health sectors. The increasing awareness of the nutritional value of fish is expected to sustain the growth of this ingredient type.

Meat Extracts:

Meat extracts, rich in proteins and nucleotides, are an essential component in the nucleotide premix market, primarily utilized in food products and animal feeds. The demand for meat extracts is driven by their flavor-enhancing properties as well as their contribution to the nutritional profile of various formulations. The growing trend of clean label products has led to an increased interest in natural meat extracts as consumers seek healthier alternatives. Furthermore, meat extracts are also gaining popularity in dietary supplements aimed at improving athletic performance and recovery, thus driving their demand in the health and wellness sector. The focus on high-quality, nutrient-dense ingredients is expected to propel the market for meat extracts in the coming years.

Seaweed Extracts:

Seaweed extracts are emerging as a preferred ingredient type in the nucleotide premix market, recognized for their rich nutrient content and bioactive compounds. The application of seaweed extracts extends across the food and beverage industry, where they are used for their health benefits and natural flavoring properties. Additionally, the demand for plant-based ingredients in dietary supplements and functional foods is driving the incorporation of seaweed extracts into various formulations. These extracts are known for their potential to improve gut health and provide antioxidants, aligning with the growing consumer preference for healthy and natural products. As the trend towards plant-based nutrition continues, seaweed extracts are expected to gain further prominence in the market.

Microbial Fermentation Extracts:

Microbial fermentation extracts represent a unique ingredient type in the nucleotide premix market, stemming from the fermentation processes of various microorganisms. These extracts are highly valued for their rich nutritional profile and functional properties, including the generation of nucleotides. The application of microbial fermentation extracts is witnessing growth in both food and pharmaceuticals, where they are used for their health benefits and potential to enhance flavor. The increasing trend of functional foods and probiotics is also propelling the demand for these extracts, as consumers seek products that promote gut health and overall wellness. The ongoing research into the benefits of microbial fermentation extracts is likely to expand their market presence over the forecast period.

By Region

The regional analysis of the nucleotide premix market reveals that North America holds a significant share, accounting for approximately 35% of the global market in 2025. The region's dominance can be attributed to the robust pharmaceutical and food industries, coupled with a growing emphasis on health and wellness among consumers. The increasing adoption of nucleotide-enriched products in dietary supplements and functional foods is propelling market growth in this region. Additionally, the presence of key industry players and continuous advancements in product formulations further enhance the competitive landscape. The North American market is projected to grow at a CAGR of around 7% during the forecast period, fueled by innovations and increasing demand.

In Europe, the nucleotide premix market is expected to experience substantial growth, driven by the rising demand for natural and functional food products. The European market is projected to account for approximately 30% of the global share by 2025, with significant contributions from the food and beverages, as well as the pharmaceutical sectors. The increasing focus on animal health and welfare is also fostering the use of nucleotide supplements in livestock feed across the region. Moreover, the growing trend of clean label products among European consumers is likely to facilitate the adoption of nucleotide premixes in various applications. The overall market growth in Europe is anticipated to be supported by increasing health awareness and regulatory support for nutritional products.

Opportunities

The nucleotide premix market presents several lucrative opportunities, particularly in the realm of product innovation. As consumer preferences shift towards natural and functional ingredients, manufacturers have the opportunity to develop unique products that leverage the health benefits of nucleotides. Innovations in product formulations that cater to specific dietary needs, such as vegan or gluten-free options, can further expand market reach and attract a diverse consumer base. Additionally, the rising trend of personalized nutrition and dietary supplements opens up avenues for companies to create tailored nucleotide products that align with individual health goals. Engaging in research and development to explore new applications and formulations will be essential for tapping into evolving consumer demands.

Furthermore, the expanding markets in developing regions present significant growth potential for nucleotide premixes. As economies grow and disposable incomes rise, consumers in these regions are becoming more health-conscious and willing to invest in nutritional products. Establishing a presence in emerging markets through strategic partnerships and local distribution channels can provide companies with a competitive edge. Additionally, leveraging digital platforms and e-commerce to reach consumers directly can enhance market penetration. The increasing focus on animal welfare and the demand for high-quality animal nutrition are also driving the need for nucleotide supplements in livestock feed, creating further opportunities for market players.

Threats

The nucleotide premix market faces several threats that could impact its growth trajectory. One of the primary challenges is the increasing competition from alternative nutritional supplements and natural ingredients that may provide similar health benefits without the need for nucleotides. As consumers become more aware of their options, they may gravitate towards products that are perceived as more natural or less processed. Additionally, the ever-changing regulatory landscape surrounding nutritional products poses a challenge for manufacturers, who must ensure compliance with various guidelines while striving to innovate. Any potential changes in regulations could lead to increased costs and delays in bringing new products to market.

Another significant threat to the nucleotide premix market is the volatility of raw material prices, which can affect production costs and profit margins. Fluctuations in the availability and cost of key ingredients used in nucleotide production, such as yeast or fish extracts, can have a direct impact on pricing strategies. Furthermore, the market is subject to economic downturns that could result in reduced consumer spending on premium nutritional products, affecting overall sales. Manufacturers must remain vigilant in managing their supply chains and maintaining cost efficiency to mitigate these threats and sustain growth.

Competitor Outlook

• Ajinomoto Co., Inc.
• Royal DSM N.V.
• Kyowa Hakko Bio Co., Ltd.
• Angel Yeast Co., Ltd.
• Fermenta Biotech Ltd.
• Ginkgo BioWorks, Inc.
• Fufeng Group Company Limited
• Hunan Er-Kang Pharmaceutical Co. Ltd.
• Wuhu Dajiang Biotechnology Co., Ltd.
• Lonza Group AG
• ChromaDex Corporation
• Skyherb Biotechnology Co., Ltd.
• Ribocon GmbH
• Alltech, Inc.
• Evonik Industries AG

The competitive landscape of the nucleotide premix market is characterized by the presence of several key players who are striving to innovate and expand their market share. Companies such as Ajinomoto Co., Inc. and Royal DSM N.V. are leading the way in terms of product development and technological advancements. Ajinomoto, recognized as a pioneer in amino acid production, has expanded its portfolio to include nucleotide premixes, catering to the rising demand for enriched nutritional products. Their extensive research and development initiatives focus on creating high-quality nucleotide formulations tailored to meet specific customer needs, thereby strengthening their market position.

Royal DSM N.V. is another major player in the nucleotide premix market, renowned for its commitment to sustainable practices and innovation. The company offers a range of nucleotide products that cater to various applications, including human nutrition and animal feed. Their focus on science-based solutions and partnerships with leading research institutions allows them to stay at the forefront of product development. Additionally, their global presence and strong distribution networks enable them to effectively meet the demands of diverse markets, enhancing their competitive advantage.

Other notable companies, such as Kyowa Hakko Bio Co., Ltd. and Angel Yeast Co., Ltd., are also making significant contributions to the market with their innovative nucleotide products. Kyowa Hakko specializes in fermentation technology and has developed a range of nucleotide premixes that support health and well-being. Similarly, Angel Yeast, a recognized leader in yeast production, is expanding its offerings to include nucleotide-rich products for both food and feed applications. The continuous focus on research and the integration of consumer insights into product development are essential strategies for these companies to remain competitive in the evolving nucleotide premix market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Ribocon GmbH
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Alltech, Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Lonza Group AG
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Royal DSM N.V.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Ajinomoto Co., Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Evonik Industries AG
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Angel Yeast Co., Ltd.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 ChromaDex Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Fermenta Biotech Ltd.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Ginkgo BioWorks, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Kyowa Hakko Bio Co., Ltd.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Fufeng Group Company Limited
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Skyherb Biotechnology Co., Ltd.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Wuhu Dajiang Biotechnology Co., Ltd.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Hunan Er-Kang Pharmaceutical Co. Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Nucleotide Premix Market, By Application
    • 6.1.1 Animal Feed
    • 6.1.2 Food & Beverages
    • 6.1.3 Pharmaceuticals
    • 6.1.4 Cosmetics
    • 6.1.5 Others
  • 6.2 Nucleotide Premix Market, By Product Type
    • 6.2.1 Guanosine 5'-Monophosphate
    • 6.2.2 Cytidine 5'-Monophosphate
    • 6.2.3 Adenosine 5'-Monophosphate
    • 6.2.4 Uridine 5'-Monophosphate
    • 6.2.5 Inosine 5'-Monophosphate
  • 6.3 Nucleotide Premix Market, By Ingredient Type
    • 6.3.1 Yeast Extracts
    • 6.3.2 Fish Extracts
    • 6.3.3 Meat Extracts
    • 6.3.4 Seaweed Extracts
    • 6.3.5 Microbial Fermentation Extracts
  • 6.4 Nucleotide Premix Market, By Distribution Channel
    • 6.4.1 Direct Sales
    • 6.4.2 Indirect Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Nucleotide Premix Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Nucleotide Premix market is categorized based on

By Product Type

• Guanosine 5'-Monophosphate
• Cytidine 5'-Monophosphate
• Adenosine 5'-Monophosphate
• Uridine 5'-Monophosphate
• Inosine 5'-Monophosphate

By Application

• Animal Feed
• Food & Beverages
• Pharmaceuticals
• Cosmetics
• Others

By Distribution Channel

• Direct Sales
• Indirect Sales

By Ingredient Type

• Yeast Extracts
• Fish Extracts
• Meat Extracts
• Seaweed Extracts
• Microbial Fermentation Extracts

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Ajinomoto Co., Inc.
• Royal DSM N.V.
• Kyowa Hakko Bio Co., Ltd.
• Angel Yeast Co., Ltd.
• Fermenta Biotech Ltd.
• Ginkgo BioWorks, Inc.
• Fufeng Group Company Limited
• Hunan Er-Kang Pharmaceutical Co. Ltd.
• Wuhu Dajiang Biotechnology Co., Ltd.
• Lonza Group AG
• ChromaDex Corporation
• Skyherb Biotechnology Co., Ltd.
• Ribocon GmbH
• Alltech, Inc.
• Evonik Industries AG